J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4):1553 -1559. doi: 10.23812/19-527-L.


Evaluation of the effect of protective genetic variants on cART success in HIV-1-infected patients.

OPEN ACCESS ARTICLE

Lori EM1, Cozzi-Lepri A2, Tavelli A3, Mercurio V1, Ibba SV1, Lo Caputo S4, Castelli F5, Castagna A6, Gori A7, Marchetti G8, Venditti C9, Clerici M10,11, D’Arminio Monforte A8, Biasin M12.

Author information

1 Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
2 Institute for Global Health, University College London. London, United Kingdom.
3 Icona Foundation, Milan, Italy.
4 Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico. Bari, Italy.
5 University Department of Infectious and Tropical Diseases, ASST degli Spedali Civili di Brescia, University of Brescia. Brescia, Italy.
6 Department of Infectious Diseases; San Raffaele Scientific Institute, University Vita-Salute San Raffaele. Milan, Italy.
7 Infectious Diseases Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, School of Medicine and Surgery, University of Milan. Milan, Italy.
8 Clinic of Infectious and Tropical Diseases, ASST Santi Paolo and Carlo, Department of Health Sciences, University of Milan. Milan, Italy.
9 UOC Microbiologia, Banca Biologica e Cell Factory, National Institute for Infectious Diseases ‘Lazzaro Spallanzani’ IRCCS. Rome, Italy.
10 Department of Physiopathology Medical-Surgery and Transplantation, University of Milan, Milan, Italy.
11 Don C. Gnocchi Foundation ONLUS, IRCCS, Milan, Italy.
12 Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy: for Icona Foundation Study Group.

KEYWORDS:

ERAP2; HAART; HIV-1; ICONA; polymorphisms

Publication type

  • Letter

You may also like...